… made to date on cellular disease modeling and drug screening using stem cell systems (ie, …
with neurological diseases. We review a few critical questions for disease modeling based …

… of small chemicals in drug development. This illustrates how iPSCs provide an improved
model system for disease modeling, high-throughput drug screening, and toxicity testing. …

… to build functional tissue models for in vitro drug screening and disease modeling. This review
… tissue models that can be used for personalized drug screening and disease modeling. In …

… the effects of drug treatment. Emerging technologies for scale-up, automation and high
throughput analysis will enable use of hiPSC-disease models for drug discovery and safety …

… on drug screening and toxicity studies, with additional interest in improving analyses of disease
models … With bioprinting as a tool, physiologically relevant models can be realized within …

… unattainable in vitro disease modeling and subsequent drug screening studies. However, …
Medicine blog ‘In the pipeline’ for further clarity on drug screening-related considerations. …

… More recently several groups have explored the possibilities of disease modeling using …
disease models but also drug screening and cell replacement therapy for various diseases. …

… , iPSCs are a great candidate for disease modeling, drug screening, and gene correction.
iPSCs … S1) using the technologies for MD disease modeling and gene correction. We point out …

… phenotype of the iPSC-CM as compared to the physiological disease phenotype… disease
model must also recapitulate physiological drug response in order to accurately evaluate drugs …

… In this review, we highlight a variety of organoid-on-a-chip systems for applications such
as drug screening and disease models, and look to the future of multi-organoid body-on-a-chip …